Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 240

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 240
---
   | 3/6/2029   |   |               — |      |          — |
| ​                  |   | 2/24/2020  |                  |         888 |   |             — |      |   588.96 |   | 2/24/2030  |   |               — |      |          — |
| ​                  |   | 3/30/2021  |                  |         831 |   |            57 | (5)​ |   741.24 |   | 3/30/2031  |   |               — |      |          — |
| ​                  |   | 2/25/2022  |                  |         784 |   |           326 | (5)​ |   376.56 |   | 2/25/2032  |   |             185 | (6)​ |   3,396.60 |
| ​                  |   | 3/1/2023   |                  |         981 |   |         1,268 | (5)​ |   362.16 |   | 3/1/2033   |   |               — |      |          — |

| (1) | Awards in this column consist of time-based restricted stock units (“RSUs”) that were unvested as of December 31, 2024. |

| (2) | The market value is based on the closing price of Cara’s common stock as of December 31, 2024 of $18.36 per share, after giving retroactive effect to the Reverse Stock Split. |

| (3) | 25% of the shares underlying the option vested on the first anniversary of the date of grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the named executive officer’s continuous service through each such date. |

| (4) | These time-based RSUs will vest in 12 equal quarterly installments through October 29, 2025, subject to the named executive officer’s continuous service as of each vesting date. |

| (5) | Shares underlying these stock options vest monthly over a four-year period from the grant date, subject to the named executive officer’s continuous service through each such date. |

| (6) | These time-based RSUs vest in three equal annual installments on the first, second and third anniversary following date of